You are viewing: US Medical Aesthetics Market analysis
Part of: Medical Aesthetics Market (Global)

The US Medical Aesthetics Market was valued at $7644.5 Million in 2025 and projected to reach to $16700.8 Million by 2031, representing a compound annual growth rate of 13.9%. The US medical aesthetics market is positioned for sustained growth through 2031, driven by evolving consumer preferences toward non-surgical beauty enhancement and increasing accessibility of treatments.

US Medical Aesthetics Market Trends and Insights

  • The US market is driven by increasing consumer demand for minimally invasive procedures, rising disposable incomes, and growing social acceptance of aesthetic treatments.
  • In the US, technological advancements in laser systems, injectables, and body contouring devices are accelerating market penetration across both urban and suburban demographics. The US medical aesthetics sector is characterized by a diverse treatment portfolio, including botulinum toxin, dermal fillers, laser resurfacing, and radiofrequency therapies.
  • The US market benefits from a well-established regulatory framework, high healthcare spending, and a strong presence of leading aesthetic device manufacturers.
  • Between 2025 and 2031, the US is expected to maintain its position as a global leader in medical aesthetics adoption, supported by favorable reimbursement policies and continuous innovation in non-surgical rejuvenation techniques..

Key Market Statistics

  • CAGR (2025-2031) 13.9% CAGR
  • Market Size, 2025 ~USD 7644.5 Million
  • Forecast, 2031 ~USD 16700.8 Million
  • Country US

US Medical Aesthetics Market Overview

Market Valuation Growth :

The US medical aesthetics market is valued at $7,644.5 million in 2025 and is projected to reach $16,700.8 million by 2031, representing a robust 13.9% CAGR over the forecast period.

Minimally Invasive Procedure Demand :

US consumers are increasingly opting for minimally invasive aesthetic procedures due to shorter recovery times, reduced risks, and growing social acceptance of cosmetic treatments across all demographics.

Rising Disposable Income Impact :

Growing disposable incomes in the US are enabling more consumers to invest in aesthetic treatments, expanding the addressable market beyond traditional high-income segments to middle-class demographics.

Technological Innovation Leadership :

Advanced laser systems, injectable formulations, and body contouring technologies are being rapidly adopted in the US market, driving procedure efficacy and patient satisfaction rates.

US Medical Aesthetics Market Dynamics

  • The market benefits from strong healthcare infrastructure, high consumer spending capacity, and continuous innovation in aesthetic technologies.
  • Injectables and laser-based treatments remain dominant segments, with emerging body contouring procedures gaining traction among US consumers seeking comprehensive aesthetic solutions. Key growth catalysts include expanding clinic networks, rising awareness through social media and influencer marketing, and improved treatment outcomes.
  • The US market's maturity and regulatory framework provide stability for market participants, while demographic shifts toward younger, more aesthetically-conscious consumers ensure sustained demand.
  • Strategic investments in technology and practitioner training will further accelerate market penetration across diverse geographic and socioeconomic segments..

Related Ecosystem

Key Takeaways

  • The US medical aesthetics market will more than double from $7,644.5M (2025) to $16,700.8M (2031), representing a 13.9% CAGR.
  • The US market is driven by consumer preference for minimally invasive procedures, technological innovation, and increasing social acceptance of aesthetic treatments.
  • The US benefits from strong regulatory frameworks, high healthcare expenditure, and a mature competitive landscape with established device manufacturers.
  • The US is positioned as a global leader in medical aesthetics adoption through 2031, supported by favorable reimbursement and continuous innovation.

Medical Aesthetics Market Report Scope

Report Metric Details
Base Year 2025
Fastest Growing Segment HOME CARE SETTINGS (End User)
Forecast Period 2025–2039
Growth Rate CAGR of 13% from 2025 to 2039
Largest Segment DERMATOLOGY CLINICS, HOSPITALS, AND MEDICAL SPAS (End User)
Market Size Base Year (Billions) ~USD 19.55 (2025)
Revenue Forecast (Billions) ~USD 40.7 (2039)
Segments Covered Product, Type, Product Type, Procedure, End User

US Medical Aesthetics Market Report Segmentation

5 segment dimensions are covered across the global market.

By Product

  • Body Contouring Devices
  • Cosmetic Implants
  • Facial Aesthetic Products
  • Hair Removal Devices
  • Nail Treatment Laser Devices
  • Physician-Dispensed Cosmeceuticals And Skin Lighteners
  • Physician-Dispensed Eyelash Products
  • Skin Aesthetic Devices
  • Sskin Aesthetic Devices
  • Tattoo Removal Devices
  • Thread Lift Products

By Type

  • Anti-Aging And Skin Rejuvenation
  • Botulinum Toxin
  • Breast Implants
  • Cellulite Reduction Devices
  • Chemical Peels
  • Dermal Fillers
  • Facelift & Body Lift Procedures
  • Facelift And Body Lift Procedures
  • Facial Implants
  • Hair Removal
  • Ipl Hair Removal Devices
  • Laser Hair Removal Devices
  • Laser Resurfacing Devices
  • Laser Skin Resurfacing Devices
  • Light Therapy Devices
  • Liposuction
  • Liposuction Devices
  • Microdermabrasion
  • Microneedling Products
  • Natural
  • Natural Dermal Fillers
  • Non-Surgical Fat Reduction Devices
  • Non-Surgical Skin Tightening Devices
  • Other Cosmetic Implants
  • Other Implants
  • Other Non-Surgical Procedures
  • Other Surgical Procedures
  • Saline
  • Saline Breast Implants
  • Silicone
  • Silicone Breast Implants
  • Synthetic
  • Synthetic Dermal Fillers
  • Tattoo Removal

By Product Type

  • At-Home/Self-Use Devices
  • Multimodal Devices
  • Standalone Devices

By Procedure

  • Non-Surgical
  • Non-Surgical Procedures
  • Surgical
  • Surgical Procedures

By End User

  • Beauty Centers
  • Clinics, Hospitals, And Medical Spas
  • Dermatology Clinics, Hospitals, And Medical Spas
  • Home Care Settings

Target Audience

  • Medical Aesthetics Clinic Operators : US clinic owners and operators need market data to assess expansion opportunities, benchmark performance against regional competitors, and make informed decisions about service offerings and technology investments.
  • Medical Device & Pharmaceutical Companies : Manufacturers of aesthetic devices, injectables, and treatments require US-specific market intelligence to guide product launches, pricing strategies, and sales force allocation across American regions.
  • Private Equity & Investment Firms : PE investors evaluating acquisition targets or portfolio companies in the US medical aesthetics space need detailed market sizing and growth projections to assess investment returns and valuation multiples.
  • Healthcare Consultants & Advisors : Consulting firms advising healthcare clients on market entry, expansion, or strategic positioning require authoritative US market data to support client recommendations and competitive analyses.
  • Market Researchers & Analysts : Research professionals covering the US healthcare and aesthetics sectors need comprehensive market reports to support industry analysis, trend identification, and stakeholder communications.

Key Companies in the US Medical Aesthetics Market

CompanyHQOwnershipStrongest segments
ALLERGAN PLCIrelandPrivate CompanyBotox,Filler,Liposuction,
SIENTRA, INC.United StatesPrivate CompanySilicone Gel Breast Implants,Body Contouring Products,Scar Management Products,
ABBVIE INC.United StatesPublic CompanyBotox Cosmetic,Juvederm Collection,Body Contouring,
GALDERMASwitzerlandPublic CompanyDermal Fillers,Botox,Laser Resurfacing,
JOHNSON & JOHNSONUnited StatesPublic CompanyFillers,Laser Resurfacing,Botox,
BAUSCH HEALTH COMPANIES INC.CanadaPublic CompanyLaser Resurfacing,RF,Fillers,
CUTERA, INC.United StatesPrivate CompanyLaser Resurfacing,RF Microneedling,Hair Removal,
LUMENIS BE LTD.IsraelPrivate CompanyLaser Hair Removal,Skin Treatment,RF and Phototherapy,
CANDELA MEDICALUnited StatesPrivate CompanyLaser Resurfacing,Hair Removal,RF and Phototherapy,
INMODE LTD.IsraelPublic CompanyRF Technology,Laser Resurfacing,Hair Removal,

ALLERGAN PLC

Allergan PLC is an Irish private company founded in 1983 with 17,400 employees. The company operates in the pharmaceutical and medical aesthetics sectors.

SIENTRA, INC.

Sientra, Inc. is a United States-based private company founded in 2003 with 304 employees. The company focuses on medical device manufacturing and aesthetics.

ABBVIE INC.

AbbVie Inc. is a publicly traded United States company founded in 2012 with 57,000 employees. The company operates as a global pharmaceutical and healthcare company.

GALDERMA

Galderma is a Swiss public company founded in 1981 with 7,676 employees. The company specializes in dermatology and aesthetic medicine products.

JOHNSON & JOHNSON

Johnson & Johnson is a publicly traded United States company founded in 1886 with 138,200 employees. The company is a diversified healthcare conglomerate operating in pharmaceuticals, medical devices, and consumer health.

BAUSCH HEALTH COMPANIES INC.

Bausch Health Companies Inc. is a Canadian public company with 20,300 employees. The company operates across pharmaceuticals, medical devices, and eye care sectors.

CUTERA, INC.

Cutera, Inc. is a United States-based private company founded in 1998 with 430 employees. The company develops and manufactures laser and light source-based aesthetic systems.

LUMENIS BE LTD.

Lumenis Be Ltd. is an Israeli private company founded in 1991 with 954 employees. The company specializes in laser and light-based medical and aesthetic devices.

CANDELA MEDICAL

Candela Medical is a United States-based private company founded in 1970 with 363 employees. The company manufactures laser and light-based medical aesthetic devices.

INMODE LTD.

InMode Ltd. is an Israeli public company founded in 2008 with 660 employees. The company develops and markets minimally invasive aesthetic medical devices.

Reasons to Buy this Report

  • Precise US Market Sizing : Access validated market valuation data specific to the United States, with detailed 2025-2031 forecasts enabling accurate financial planning and investment decisions for US-focused business strategies.
  • Competitive Intelligence : Understand the US competitive landscape, identify market gaps, and benchmark against regional players to develop differentiated go-to-market strategies tailored to American consumer preferences and regulatory requirements.
  • Segment-Specific Insights : Gain detailed analysis of US market segments including injectables, laser systems, and body contouring procedures, enabling targeted product development and marketing initiatives for specific aesthetic categories.
  • Consumer Behavior Analysis : Leverage insights into US consumer demographics, purchasing patterns, and treatment preferences to optimize pricing strategies, service offerings, and patient acquisition channels specific to the American market.
  • Growth Opportunity Identification : Identify high-growth geographic regions within the US, emerging procedure categories, and underserved demographic segments to prioritize expansion efforts and maximize return on investment.

Frequently asked questions

What is the current size of the US medical aesthetics market in 2025?

The US medical aesthetics market is valued at $7,644.5 million in 2025, with expectations to grow significantly through 2031.

What is the projected market size for the US medical aesthetics market by 2031?

The US medical aesthetics market is projected to reach $16,700.8 million by 2031, representing more than a doubling of market value.

What is the CAGR for the US medical aesthetics market?

The US medical aesthetics market is expected to grow at a compound annual growth rate (CAGR) of 13.9% from 2025 to 2031.

What are the primary drivers of growth in the US medical aesthetics market?

Key growth drivers in the US include increasing consumer demand for minimally invasive procedures, rising disposable incomes, technological advancements, and growing social acceptance of aesthetic treatments.

Which treatment modalities dominate the US medical aesthetics market?

The US market is led by botulinum toxin, dermal fillers, laser resurfacing, and radiofrequency therapies, with continuous innovation expanding treatment options.

RESEARCH METHODOLOGY

Four primary studies have been undertaken to size the medical aesthetics market. Secondary research has been used to obtain preliminary data for the medical aesthetics market and peer and parent markets. Data were collected from 3–5 secondary sources and validated by primary sources for assumptions and market sizing. Through top-down and bottom-up approaches, the overall market size was informed and further broken down, and data was triangulated for segment and subsegment sizing.

Secondary Research

Secondary research included directories, Factiva, white papers, Bloomberg Businessweek, annual reports, SEC filings, business filings, and investor presentations, among others. Through these sources, one can gain critical data about market leaders, how the industry is divided into sectors, and how technology varies from one industry level to another within medical aesthetics.

Primary Research

Primary research included interviewing people from the supply side of the business and the demand side to get quantitative and qualitative insights. On the demand side, primary sources involved in the study included physicians, researchers, department heads, staff from diagnostic centers, hospital staff, and those attached to the research institutes. On the supply side, these sources involved CEOs, area sales managers, territory and regional sales managers, and various other top executives of relevant companies. These direct meetings with people in key leadership positions helped validate assumptions arising from secondary research and bring them face-to-face so that any assumptions could also be directly questioned.

A breakdown of the primary respondents is provided below:

Medical Aesthetics Market  Size, and Share

Notes:
*Others include Sales Managers, Marketing Managers, Business Development Managers, Product Managers, Distributors, and Suppliers.
Companies are classified into tiers based on their total revenue. As of 2025, the following tiers have been used:
Tier 1 = > USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The revenue share analysis of major companies was used in this report to determine the size of the global medical aesthetics market. This was accomplished by identifying the major market participants and calculating their medical aesthetics business revenues using a variety of information acquired throughout the primary and secondary research stages. Examining the annual and financial reports of the leading market participants was one aspect of secondary research. On the other hand, primary research involved in-depth interviews with important thought leaders, including directors, CEOs, and important marketing executives. Segmental revenues were computed using the revenue mapping of the leading solution/service providers to determine the worldwide market value.
The following steps were involved in this process:

  • Making a list of the leading international companies in the medical aesthetics industry
  • Charting the annual profits made by the leading companies in the medical aesthetics sector (or the closest stated business unit/product category)
  • Calculating the medical aesthetics industry’s global value
  • As of 2025, revenue mapping of leading companies is expected to cover a significant portion of the global market.

Medical Aesthetics Market : Top-Down and Bottom-Up Approach

Medical Aesthetics Market Top Down and Bottom Up Approach

Data Triangulation

After determining the overall market size through the process of estimation as discussed above, the global medical aesthetics market has been segmented and subsegmented. Data triangulation and market breakdown methods have been used to refine the accuracy of these estimates. This process is based on the analysis of multiple factors and trends from the demand and supply perspectives. The medical aesthetics market has been validated through the top-down and bottom-up approaches, ensuring the accuracy of the segment and subsegment statistics.

Market Definition

The medical aesthetics market comprises products and procedures designed to enhance aesthetic appearance through non-surgical or surgical interventions targeting facial, skin, body, hair, and nail cosmetic concerns. The market includes facial aesthetic products, body contouring devices, cosmetic implants, skin aesthetic devices, physician-dispensed eyelash products, hair removal devices, tattoo removal devices, thread lift products, nail treatment laser devices, and home care aesthetic devices. The market serves end users, including clinics, hospitals, medical spas, beauty centers, and home care settings.

Key Stakeholders

  • Medical Aesthetic Clinics
  • Healthcare Providers
  • Distributors and Suppliers
  • Regulatory Authorities
  • Cosmetologists and Plastic Surgeons
  • Investors and Private Equity Firms
  • Media and Influencers
  • Market Research and Consulting Firms

Report Objectives

  • To define, describe, and forecast the medical aesthetics market based on product, product type, procedure, end user, and region
  • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
  • To analyze the micro markets for individual growth trends, prospects, and contributions to the overall medical aesthetics market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments for five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and analyze their market shares and core competencies
  • To track and analyze competitive developments, such as product launches, funding and grants, partnerships, agreements, collaborations, expansions, strategic alliances, and acquisitions
  • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework to analyze players on various parameters within the broad categories of business and product excellence strategy

Available customizations:

  • Using market data, MarketsandMarkets provides customization as per the company's requirements. The following customization options are available:

Product Analysis

  • Product matrix, which offers a comparison of the product offerings of the top 5 companies

Regional Analysis

  • Further breakdown of the Rest of Europe medical aesthetics market into Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal, among others
  • Further breakdown of the Rest of Asia Pacific medical aesthetics market into  Singapore, Taiwan, New Zealand, the Philippines, Malaysia, and other Asia Pacific countries
  • Further breakdown of the Rest of Latin America medical aesthetics market into Argentina, Chile, Colombia, and others

Company Information

  • Detailed description and profiling of additional market players (up to 5)

 

Get the Full Medical Aesthetics Market Report

Full forecast, segment splits, and company analysis for all Medical Aesthetics Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status